Exclusivity Information
Bonqat holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2028. Details of Bonqat's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Nov 17, 2028 |
About Bonqat
Bonqat is a drug
owned by ORION CORP.
Bonqat uses
Pregabalin as the active
ingredient.
Active Ingredient:
Bonqat uses
Pregabalin as the active ingredient.
Check out other Drugs and Companies using
Pregabalin ingredient.